Inclusive language must lead to accurate care
An inclusive service asks and correctly uses a person's name, pronouns, gender identity, sexual orientation and words for body parts without treating disclosure as a spectacle. It also takes a precise sexual history based on practices, anatomy, partners, pregnancy possibility and goals. Identity labels alone do not determine contraception, STI exposure, cancer-screening needs or fertility plans.
ACOG advises screening any anatomical structure that is present and warrants screening, regardless of gender identity [1]. This anatomy and exposure approach avoids two common errors: denying needed cervical or breast screening because of gender identity, and assuming that every transgender or nonbinary person has the same anatomy, hormones or goals. Questions should have an explicit clinical reason and the patient should be told why they are asked.
- Ask which organs are present only when relevant to care.
- Base STI testing on sites of exposure and sexual practices.
- Do not infer pregnancy risk from appearance, identity or testosterone use.
Contraception and pregnancy need direct discussion
Gender-affirming hormone therapy is not contraception. ACOG advises that people with retained gonads who have sex that brings sperm and oocytes together need counselling about pregnancy possibility if pregnancy is not desired [1]. A respectful consultation asks whether pregnancy is possible, wanted now, wanted later or to be avoided, and then reviews options without assuming parenthood preferences.
Sexual health care should include consent, pleasure, pain, function, STI prevention and relationship safety. ACOG notes that lesbian and bisexual women can acquire HPV, herpes, bacterial vaginosis and other infections, and recommends prevention and screening based on exposure rather than myths of negligible risk [2]. WHO defines sexual health as physical, emotional, mental and social wellbeing, not merely absence of disease [3].
- Use neutral questions about partners and practices.
- Discuss contraception separately from gender-affirming hormones.
- Include pleasure, pain and goals in sexual-health assessment.
Family building should not require proving infertility
ASRM states that fertility services should be available irrespective of marital status, sexual orientation or gender identity [4]. Pathways can include donor sperm, donor oocytes, gestational carrier arrangements, intrauterine insemination, IVF, reciprocal IVF, fertility preservation and adoption according to anatomy, jurisdiction, values and clinical circumstances. Requirements should be consistent across patient groups.
Transgender and nonbinary people should be offered fertility-preservation counselling before interventions that may affect reproductive potential, while being free to decline [5]. The discussion must not imply that transition should be delayed or that biological parenthood is required. Evidence on long-term reproductive outcomes after some gender-affirming treatments remains limited, so counselling should distinguish known effects, uncertainty and available options.
- Review fertility goals early and revisit them without pressure.
- Apply the same psychosocial and clinical standards to all intended parents.
- Explain legal parentage and donor rules with jurisdiction-appropriate expertise.
Trauma-informed design improves ordinary clinical quality
A clinic becomes meaningfully inclusive when its registration forms, toilets, imaging pathways, laboratory ranges, fertility consents and billing systems work for diverse families. A rainbow symbol cannot compensate for a portal that exposes a former name or a waiting room that repeatedly misgenders patients. Staff need workflows for correcting records while preserving clinically relevant history and legal requirements.
Pelvic examinations, ultrasound and fertility procedures may trigger dysphoria or prior trauma. ACOG recommends trauma-informed, inclusive care for transgender and gender-diverse people [1]. Clinicians can explain each step, ask consent before touch, offer self-insertion of swabs where validated, allow a support person and agree on stop signals. Avoiding necessary care is not the only answer. The goal is to make indicated care tolerable, respectful and clinically accurate.
- Audit names and pronouns across every system, not only the clinical note.
- Offer procedural choices without reducing diagnostic quality.
- Train all staff, including reception, imaging, laboratory and billing teams.
Technology should widen access without flattening identity
Telehealth can connect people to specialised sexual-health, fertility and gender-informed clinicians, particularly where local services are scarce. WHO's 2024 package for trans and gender-diverse people supports accessible HIV, hepatitis and STI prevention, diagnosis and care [6]. Digital reach does not solve local laboratory, imaging, medicine or safeguarding needs, so hybrid pathways and referral ownership remain important.
Algorithms trained on binary sex fields can produce wrong reference ranges, screening reminders or pregnancy assumptions. Systems should separate sex-related clinical variables, gender identity, anatomy, hormones and pregnancy potential rather than forcing one field to do every job. Access controls must protect sensitive identity information. Patients need to know which data are used for care, billing, reporting and research and how to correct errors.
- Test clinical decision support with transgender and nonbinary scenarios.
- Do not display sensitive identity data more widely than necessary.
- Measure missed screening and treatment completion across LGBTQ+ groups.
What the evidence cannot yet answer
- Many LGBTQ+ health studies combine diverse populations or use small samples, limiting subgroup-specific conclusions.
- Long-term fertility and pregnancy evidence after some gender-affirming treatments remains limited.
- Legal rules for donors, gestational carriers, parentage and fertility treatment differ substantially by country and can change.
Questions worth taking into care
- Which name, pronouns and body terms should the team use?
- Which anatomy and exposures are relevant to today's screening or symptoms?
- Is pregnancy possible, desired now, desired later or to be avoided?
- What fertility-preservation or family-building options fit the person's goals and jurisdiction?
- Can the record system protect sensitive information and correct a former name across every touchpoint?
Source record
Evidence used in this review
Sources were selected for clinical authority, methodological relevance and traceability. Links open the original guidance, public-health record or research publication.
- [1]Health Care for Transgender and Gender Diverse Individuals
American College of Obstetricians and Gynecologists · 2021
- [2]Health Care for Lesbians and Bisexual Women
American College of Obstetricians and Gynecologists · 2012
- [3]Defining Sexual Health
World Health Organization · 2006
- [4]Access to Fertility Treatment Irrespective of Marital Status, Sexual Orientation, or Gender Identity
American Society for Reproductive Medicine · 2021
- [5]Access to Fertility Services by Transgender and Nonbinary Persons
American Society for Reproductive Medicine · 2021
- [6]Recommended Package for HIV, Viral Hepatitis and STI Care for Trans and Gender Diverse People
World Health Organization · 2024
This evidence synthesis is for general information. It does not diagnose a condition or replace care from a qualified health professional. Treatment choices depend on individual history, examination, local guidance and informed preference. Emergency or rapidly worsening symptoms need urgent local medical assessment.



